Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Fleseriu

Showing results (11-20 of 268) with videos related to

Pageof 27
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|March 24, 2021
Cushing's syndrome Part 2: Advances in Treatment and in Understanding Complications' ImpactMaria Fleseriu
Pituitary|December 17, 2010
Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature reviewMaria Fleseriu
Current Opinion in Endocrinology, Diabetes, and Obesity|June 29, 2013
The role of combination medical therapy in acromegaly: hope for the nonresponsive patientMaria Fleseriu
Discovery Medicine|July 1, 2014
Advances in the pharmacotherapy of patients with acromegalyMaria Fleseriu
The Journal of Clinical Endocrinology and Metabolism|October 26, 2019
Fertility and Pregnancy in Women With Hypopituitarism: A Systematic Literature ReviewGreisa Vila, Maria Fleseriu
Journal of Neuro-Oncology|May 16, 2013
New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapyMaria Fleseriu, Stephan Petersenn
Pituitary|September 8, 2016
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesMaria Fleseriu, Frederic Castinetti
Pituitary|January 29, 2015
Pituitary-directed medical therapy in Cushing's diseaseStephan Petersenn, Maria Fleseriu
Pituitary|March 12, 2015
Cushing disease: where do we stand, where are we heading?Maria Fleseriu, Stephan Petersenn
Pituitary|January 7, 2015
Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockersMaria Fleseriu, Stephan Petersenn
Pageof 27

Showing results (11-20 of 268) with videos related to

Sort By:
Pageof 27
Best Practice & Research. Clinical Endocrinology & Metabolism|March 24, 2021
Cushing's syndrome Part 2: Advances in Treatment and in Understanding Complications' ImpactMaria Fleseriu
Pituitary|December 17, 2010
Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature reviewMaria Fleseriu
Current Opinion in Endocrinology, Diabetes, and Obesity|June 29, 2013
The role of combination medical therapy in acromegaly: hope for the nonresponsive patientMaria Fleseriu
Discovery Medicine|July 1, 2014
Advances in the pharmacotherapy of patients with acromegalyMaria Fleseriu
The Journal of Clinical Endocrinology and Metabolism|October 26, 2019
Fertility and Pregnancy in Women With Hypopituitarism: A Systematic Literature ReviewGreisa Vila, Maria Fleseriu
Journal of Neuro-Oncology|May 16, 2013
New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapyMaria Fleseriu, Stephan Petersenn
Pituitary|September 8, 2016
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesMaria Fleseriu, Frederic Castinetti
Pituitary|January 29, 2015
Pituitary-directed medical therapy in Cushing's diseaseStephan Petersenn, Maria Fleseriu
Pituitary|March 12, 2015
Cushing disease: where do we stand, where are we heading?Maria Fleseriu, Stephan Petersenn
Pituitary|January 7, 2015
Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockersMaria Fleseriu, Stephan Petersenn
Pageof 27